Low does of aspirin long-term reduces the incidence of colon cancer by a quarter, research published this morning shows. Researchers from Oxford University carried out the first study to assess the long-term effectiveness of aspirin on colorectal cancer incidence and mortality and report their results in The Lancet. DIT Library subscribes to the Lancet e-journal - read the article here. If you are accessing this article from outside the DIT network you'll be asked for your student/staff number and Library PIN.